Financial Advisory Partners, LLC Abbott Laboratories Transaction History

Financial Advisory Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$90.19 - $110.4 $23,178 - $28,372	-257 Reduced 0.72%	35,223 $3.88 Billion
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $67,921 - $81,494	-711 Reduced 1.96%	35,480 $3.44 Billion
Q2 2023 Oct 04, 2023	BUY	$100.78 - $112.29 $10,783 - $12,015	107 Added 0.3%	36,191 $3.95 Billion
Q1 2023 Oct 04, 2023	BUY	$96.86 - $114.01 $114,488 - $134,759	1,182 Added 3.39%	36,084 $3.65 Billion
Q4 2022 Oct 04, 2023	SELL	$95.06 - $111.52 $39,735 - $46,615	-418 Reduced 1.18%	34,902 $3.83 Billion
Q3 2022 Oct 04, 2023	BUY	$96.76 - $112.03 $29,415 - $34,057	304 Added 0.87%	35,320 $3.42 Billion
Q2 2022 Oct 04, 2023	BUY	$102.07 - $123.37 $108,296 - $130,895	1,061 Added 3.12%	35,016 $3.8 Billion
Q1 2022 Oct 04, 2023	BUY	$114.02 - $139.04 $62,596 - $76,332	549 Added 1.64%	33,955 $4.02 Billion
Q4 2021 Oct 04, 2023	BUY	$115.53 - $141.46 $3.86 Million - $4.73 Million	33,406 New	33,406 $4.7 Billion

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Financial Advisory Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Advisory Partners, LLC with notifications on news.